- Home
- TOVX vs VERO Comparison
TOVX vs VERO Comparison
Compare TOVX & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- VERO
- Stock Information
- Founded
- TOVX 2001
- VERO N/A
- Country
- TOVX United States
- VERO Canada
- Employees
- TOVX N/A
- VERO N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- TOVX Health Care
- VERO Health Care
- Exchange
- TOVX Nasdaq
- VERO Nasdaq
- Market Cap
- TOVX 3.1M
- VERO 3.1M
- IPO Year
- TOVX 2006
- VERO N/A
- Fundamental
- Price
- TOVX $1.37
- VERO $0.31
- Analyst Decision
- TOVX Strong Buy
- VERO
- Analyst Count
- TOVX 1
- VERO 0
- Target Price
- TOVX $6.00
- VERO N/A
- AVG Volume (30 Days)
- TOVX 4.8M
- VERO 2.3M
- Earning Date
- TOVX 11-12-2024
- VERO 11-13-2024
- Dividend Yield
- TOVX N/A
- VERO N/A
- EPS Growth
- TOVX N/A
- VERO N/A
- EPS
- TOVX N/A
- VERO N/A
- Revenue
- TOVX N/A
- VERO $67,200,000.00
- Revenue This Year
- TOVX N/A
- VERO N/A
- Revenue Next Year
- TOVX N/A
- VERO $7.56
- P/E Ratio
- TOVX N/A
- VERO N/A
- Revenue Growth
- TOVX N/A
- VERO N/A
- 52 Week Low
- TOVX $1.24
- VERO $0.28
- 52 Week High
- TOVX $17.00
- VERO $2.22
- Technical
- Relative Strength Index (RSI)
- TOVX 37.71
- VERO 34.77
- Support Level
- TOVX $1.31
- VERO $0.38
- Resistance Level
- TOVX $2.22
- VERO $0.44
- Average True Range (ATR)
- TOVX 0.24
- VERO 0.07
- MACD
- TOVX -0.00
- VERO -0.01
- Stochastic Oscillator
- TOVX 4.51
- VERO 7.27
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.